• Clinical oncology in this era coalesced around expanding treatment modalities—radium and external beam radiotherapy, surgical classifications linked to prognosis, hormonal manipulation of prostate cancer, and early chemotherapy status, signaling a shift toward combined modality management and cancer care optimization [9], [10], [11], [13], [20].

• Pathology-centric cancer research emphasized tumor biology, histological criteria, and metastasis mapping—surveys of lymphomas, minimal histologic changes for diagnosis, and metastasis incidence to adrenals and rectum, revealing early systemic patterns that shaped staging and treatment planning [2], [5], [12], [17], [18].

• Hematologic malignancies and pharmacology matured into identifiable research domains, with leukemia-focused studies, folic acid antagonists, and emerging anti-cancer agent exploration, foreshadowing modern chemotherapy paradigms and pharmacotherapy in oncology [3], [4], [10], [14].

• Translational cancer research leveraged animal models and methodological innovations, from X-ray irradiation studies yielding ovarian tumor insights to rat tissue fixation approaches aiding treatment planning, illustrating early bench-to-bedside translation [8], [19].